News Articles Featured Nov 4, 2024 Cannabinoid Product Holds Promise for Patients in Pain Nov 4, 2024 Nov 4, 2024 May 2, 2024 BRC Featured in Stanford Business Magazine for its Novel Approach to Cannabinoid Drugs May 2, 2024 May 2, 2024 Jun 14, 2023 Coffee Talk Podcast: Exploring Cannabis' Role in Longevity with Hunter Land, PhD Jun 14, 2023 Jun 14, 2023 Apr 17, 2023 Cannabinoid Researcher Urges Industry to Adopt Scientific Mindset Apr 17, 2023 Apr 17, 2023 May 18, 2021 DEA finally ends fed monopoly on schwaggy research-grade cannabis May 18, 2021 May 18, 2021 May 18, 2021 DEA close to allowing companies to grow cannabis for scientific research May 18, 2021 May 18, 2021 May 18, 2021 DEA finally issues permits to grow research-grade pot May 18, 2021 May 18, 2021 May 17, 2021 US growing approvals a ‘monumental’ step away from Trump moratorium on pot licensing May 17, 2021 May 17, 2021 May 14, 2021 DEA finally ready to end federal marijuana research monopoly May 14, 2021 May 14, 2021 May 14, 2021 Marijuana medical research growers receive U.S. approval May 14, 2021 May 14, 2021 Press Releases Featured Dec 3, 2024 BRC-002 receives Orphan Drug Designation from FDA for Complex Regional Pain Syndrome Dec 3, 2024 Dec 3, 2024 Oct 3, 2024 Biopharmaceutical Research Company Announces First Dose of BRC-002, a First-in-Class Cannabinoid Therapeutic for Complex Regional Pain Syndrome (CRPS), in Investigator-Initiated Study Oct 3, 2024 Oct 3, 2024 Sep 12, 2024 First patient received BRC-001, a cannabinoid therapeutic, in a clinical trial investigating supportive care in breast cancer at City of Hope. Sep 12, 2024 Sep 12, 2024 Oct 4, 2022 DEA-Licensed Cannabis Company Raises $20 Million Oct 4, 2022 Oct 4, 2022 Contact Us →
